New TABAs technique in coronary bifurcation stenosis treatment

New TABAs technique in coronary bifurcation stenosis treatment

Percutaneous coronary intervention (PCI) in coronary bifurcation stenosis is still regarded as technically complicated, due to the risk of lateral branch occlusion. Bifurcation stenosis is also characterised by higher intervention costs and restenosis incidence. Over the last 10 years, a range of ne...

Full description

Bibliographic Details
Main Authors:	T. A. Batyraliev, D. V. Fetser, Yu. N. Belenkov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	чрескожные коронарные вмешательства бифуркационные стенозы ишемическая болезнь сердца техника tabas стенты выделяющие лекарства
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1652

Similar Items

ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF CLOPIDOGREL RESISTANCE AMONG PATIENTS REFERRED FOR PERCUTANEOUS CORONARY INTERVENTIONS
by: S. T. Matskeplishvili, et al.
Published: (2013-08-01)

Этнические особенности при чрескожных коронарных вмешательствах по данным «Регистра проведенных операций траслюминальной баллонной коронарной ангиопластики»
by: V. A. Kuznetsov, et al.
Published: (2018-04-01)

Predictors of long term adverse events after scheduled endovascular coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-08-01)

ТЕСТ ГЕНЕРАЦИИ ТРОМБИНА В ОЦЕНКЕ ДЕЙСТВИЯ АНТИАГРЕГАНТОВ У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА ПОСЛЕ ЧРЕСКОЖНОГО КОРОНАРНОГО ВМЕШАТЕЛЬСТВА
by: Г. А. Березовская, et al.
Published: (2015-07-01)

Prospective registry of percutaneous coronary interventions: Tyumen Cardiology Center’s experience
by: В. А. Кузнецов, et al.
Published: (2015-10-01)

Periinterventional cardiovascular risk and the methods for its reduction in coronary heart disease patients undergoing percutaneous coronary intervention
by: K. A. Nazarova, et al.
Published: (1970-01-01)

EVALUATION OF STRENGTH CHARACTERISTICS OF CORONARY STENTS IN THE CREATED MODEL OF “MYOCARDIAL BRIDGE”
by: V. V. Plechev, et al.
Published: (2018-08-01)

CLINICAL CHARACTERISTICS OF ISCHEMIC HEART DISEASE PATIENTS WITH TYPE D PERSONALITY, UNDERWENT PERCUTANEOUS CORONARY INTERVENTIONS
by: G. S. Pushkarev, et al.
Published: (2015-06-01)

Stents in coronary heart disease patients: review of the studies available
by: L. A. Bokeriya, et al.
Published: (2009-02-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

COURAGE study results: disappointing or encouraging?
by: D. M. Aronov, et al.
Published: (1970-01-01)

ANALYSIS OF LONG TERM RESULTS OF MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE WITH A HIGH LEVEL OF TREATMENT ADHERENCE
by: N. Yu. Sokolova, et al.
Published: (2017-08-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

STATINS IN ACUTE CORONARY SYNDROMES
by: A. L. Alyavi, et al.
Published: (2019-03-01)

Physical rehabilitation after percutaneous coronary intervention: new perspectives of rehabilitation programme integration into ambulatory healthcare system
by: N. P. Lyamina, et al.
Published: (1970-01-01)

NICHE OF PRASUGREL AMONG OTHER PLATELET P2Y12-RECEPTOR INHIBITORS
by: P. S. LAGUTA, et al.
Published: (2017-12-01)

How real is a threat of late thrombosis for drug-eluting stents? Stent comparison and focus on everolimus
by: V. P. Lupanov, et al.
Published: (2009-10-01)

Biomarker levels, left ventricular dysfunction, and severity of coronary pathology in elderly patients with coronary heart disease
by: L. R. Mirzakhanova, et al.
Published: (2012-10-01)

LONG TERM SURVIVAL OF MYOCARDIAL INFARCTION PATIENTS COMPLICATED WITH CARDIOGENIC SHOCK
by: D. V. Kryuchkov, et al.
Published: (2015-04-01)

EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM
by: A. L. Komarov
Published: (2015-12-01)

Long-term clinical results of coronary angioplasty with sirolimus-eluting stents in patients with Type 2 diabetes mellitus
by: K. N. Petrova, et al.
Published: (2008-10-01)

Stent-Graft Treatment of Anterior Interventricular Artery Extravasation Type IIICS: a Clinical Case
by: M. O. Loginov, et al.
Published: (2020-12-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

BIORESORBABLE VASCULAR SCAFFOLDS (SYSTEMATIC LITERATURE REVIEW)
by: Vladimir Plechev, et al.
Published: (2017-12-01)

State of microcircuiation in cardiac chamber walls in elderly patients with aortic stenosis combined with coronary heart disease
by: A. M. Karaskov, et al.
Published: (2018-06-01)

IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION
by: P. A. Shesternya, et al.
Published: (2015-09-01)

The specific features of the diagnosis and treatment of coronary heart disease in rheumatoid arthritis (Results of the authors’ studies)
by: Natalya Anatolyevna Khramtsova, et al.
Published: (2012-06-01)

Role of Lipid-Rich Plaques in Outcomes of Drug-Eluting Stent Implantation in Patients with Coronary Artery Disease
by: I. A. Mustafina, et al.
Published: (2019-03-01)

РЕКОМЕНДАЦИИ ПО РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА
Published: (2016-01-01)

РЕКОМЕНДАЦИИ ПО РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА
Published: (2016-01-01)

Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention
by: M. P. Mal’gina, et al.
Published: (2007-06-01)

Effectiveness of lipid-lowering therapy in outpatients with coronary artery disease living in a large industrial center of Eastern Siberia
by: N. G. Gogolashvili, et al.
Published: (2022-01-01)

Entretien avec Patrick Deville : « J’ai décidé de devenir écrivain vers 7 ou 8 ans pour écrire ce livre-là : Taba-Taba »
by: Marina Ortrud Hertrampf, et al.
Published: (2019-05-01)

PECULIAR FEATURES OF PTCA IN CORONARY PATIENTS WITH BIFURCATION LESIONS
by: A. O. Oleynik, et al.
Published: (2002-10-01)

Relationship between coronary artery calcification and osteopenic syndrome in men with coronary heart disease
by: T. A. Raskina, et al.
Published: (2016-06-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

О ФАКТОРАХ РИСКА, ОСОБЕННОСТЯХ ТЕЧЕНИЯ И КРИТЕРИЯХ ДИАГНОСТИКИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
by: О. Н. Сигитова, et al.
Published: (2013-10-01)

CEREBROVASCULAR PATHOLOGY IN PATIENTS WITH CORONARY HEART DISEASE (NEROIMAGING RESULTS)
by: Irina Danilovna Syrova, et al.
Published: (2023-09-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)